Similar articles for PMID: 21119185

Year	Number of Results
2003	1
2005	1
2006	4
2007	3
2008	4
2009	6
2010	7
2011	6
2012	4
2013	13
2014	12
2015	7
2016	7
2017	11
2018	5
2019	3
2020	6
2021	5
2022	2
2024	0

1

Treat-to-target strategies in pulmonary arterial hypertension: the importance of using multiple goals.

Sitbon O, Galiè N. Sitbon O, et al. Eur Respir Rev. 2010 Dec;19(118):272-8. doi: 10.1183/09059180.00008210. Eur Respir Rev. 2010. PMID: 21119185 Free PMC article. Review.

2

Treatment goals of pulmonary hypertension.

McLaughlin VV, Gaine SP, Howard LS, Leuchte HH, Mathier MA, Mehta S, Palazzini M, Park MH, Tapson VF, Sitbon O. McLaughlin VV, et al. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D73-81. doi: 10.1016/j.jacc.2013.10.034. J Am Coll Cardiol. 2013. PMID: 24355644 Free article. Review.

3

Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course.

Baldi F, Fuso L, Arrighi E, Valente S. Baldi F, et al. Ther Clin Risk Manag. 2014 Oct 7;10:825-39. doi: 10.2147/TCRM.S48920. eCollection 2014. Ther Clin Risk Manag. 2014. PMID: 25328398 Free PMC article. Review.

4

Management of severe pulmonary arterial hypertension.

Vachiéry JL, Simonneau G. Vachiéry JL, et al. Eur Respir Rev. 2010 Dec;19(118):279-87. doi: 10.1183/09059180.00008010. Eur Respir Rev. 2010. PMID: 21119186 Free PMC article. Review.

5

Optimal management of severe pulmonary arterial hypertension.

Sitbon O, Simonneau G. Sitbon O, et al. Eur Respir Rev. 2011 Dec;20(122):254-61. doi: 10.1183/09059180.00007011. Eur Respir Rev. 2011. PMID: 22130818 Free PMC article. Review.

6

Is it possible to apply the treat-to-target strategy in primary Sjögren's syndrome-associated pulmonary arterial hypertension?

Liu Z, Wang J, Lai J, Wang Q, Zhao J, Huang C, Yang X, Qian J, Wang H, Guo X, Liu Y, Tian Z, Li M, Zhao Y, Zeng X. Liu Z, et al. Clin Rheumatol. 2018 Nov;37(11):2989-2998. doi: 10.1007/s10067-018-4184-1. Epub 2018 Jul 24. Clin Rheumatol. 2018. PMID: 30039269

7

[Treatment goals in pulmonary arterial hypertension].

Savale L, Sitbon O. Savale L, et al. Presse Med. 2010 Jun;39 Suppl 1:1S33-40. doi: 10.1016/S0755-4982(10)70005-1. Presse Med. 2010. PMID: 20732616 French.

8

[Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].

Kaemmerer H, Gorenflo M, Hoeper M, Huscher D, Ewert P, Pittrow D. Kaemmerer H, et al. Dtsch Med Wochenschr. 2013 Jun;138(23):1247-52. doi: 10.1055/s-0033-1343189. Epub 2013 May 29. Dtsch Med Wochenschr. 2013. PMID: 23720182 Review. German.

9

Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials.

Benza RL, Gomberg-Maitland M, Naeije R, Arneson CP, Lang IM. Benza RL, et al. J Heart Lung Transplant. 2011 Sep;30(9):982-9. doi: 10.1016/j.healun.2011.03.011. Epub 2011 May 4. J Heart Lung Transplant. 2011. PMID: 21531577 Clinical Trial.

10

[Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].

Xu ZY, Li QQ, Zhang C, Zhang HS, Gu H. Xu ZY, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Apr 24;48(4):315-322. doi: 10.3760/cma.j.cn112148-20190628-00364. Zhonghua Xin Xue Guan Bing Za Zhi. 2020. PMID: 32370483 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

98 results

Results by year